AMG 397 is an oral small molecule inhibitor of MCL-1. It is being investigated as a treatment for multiple myeloma, acute myeloid leukemia, and non-hodgkins lymphoma.
| SparkCures ID | 330 |
|---|---|
| Developed By | Amgen |
| Generic Name | AMG 397 |
There are no resources, links or videos to display for this treatment.